Detalhe da pesquisa
1.
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy.
Open Forum Infect Dis
; 11(3): ofad694, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38449916
2.
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.
Lancet Gastroenterol Hepatol
; 7(4): 307-317, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35026142
3.
Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV.
J Acquir Immune Defic Syndr
; 87(5): e234-e236, 2021 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33929394